Development and validation of a survey instrument for assessing prescribers' perception of computerized drug-drug interaction alerts

被引:18
|
作者
Zheng, Kai [1 ,2 ]
Fear, Kathleen [2 ]
Chaffee, Bruce W. [3 ,4 ]
Zimmerman, Christopher R. [3 ,4 ]
Karls, Edward M. [5 ]
Gatwood, Justin D. [3 ]
Stevenson, James G. [3 ,4 ]
Pearlman, Mark D. [6 ]
机构
[1] Univ Michigan, Dept Hlth Management & Policy, Sch Publ Hlth, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Pharm Serv, Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Qual Improvement, Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Obstet & Gynecol, Sch Med, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
CLINICAL DECISION-SUPPORT; PHYSICIAN ORDER ENTRY; INFORMATION-TECHNOLOGY; USER ACCEPTANCE; HEALTH-CARE; MEDICATION SAFETY; CONCEPTUAL-MODEL; SYSTEMS; ADOPTION; IMPACT;
D O I
10.1136/amiajnl-2010-000053
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective To develop a theoretically informed and empirically validated survey instrument for assessing prescribers' perception of computerized drug-drug interaction (DDI) alerts. Materials and methods The survey is grounded in the unified theory of acceptance and use of technology and an adapted accident causation model. Development of the instrument was also informed by a review of the extant literature on prescribers' attitude toward computerized medication safety alerts and common prescriber-provided reasons for overriding. To refine and validate the survey, we conducted a two-stage empirical validation study consisting of a pretest with a panel of domain experts followed by a field test among all eligible prescribers at our institution. Results The resulting survey instrument contains 28 questionnaire items assessing six theoretical dimensions: performance expectancy, effort expectancy, social influence, facilitating conditions, perceived fatigue, and perceived use behavior. Satisfactory results were obtained from the field validation; however, a few potential issues were also identified. We analyzed these issues accordingly and the results led to the final survey instrument as well as usage recommendations. Discussion High override rates of computerized medication safety alerts have been a prevalent problem. They are usually caused by, or manifested in, issues of poor end user acceptance. However, standardized research tools for assessing and understanding end users' perception are currently lacking, which inhibits knowledge accumulation and consequently forgoes improvement opportunities. The survey instrument presented in this paper may help fill this methodological gap. Conclusion We developed and empirically validated a survey instrument that may be useful for future research on DDI alerts and other types of computerized medication safety alerts more generally.
引用
收藏
页码:I51 / I61
页数:11
相关论文
共 50 条
  • [1] Prescribers' reported acceptance and use of drug-drug interaction alerts: An Australian survey
    Baysari, Melissa T.
    Van Dort, Bethany A.
    Zheng, Wu Yi
    Li, Ling
    Hilmer, Sarah
    Westbrook, Johanna
    Day, Richard
    HEALTH INFORMATICS JOURNAL, 2022, 28 (02)
  • [2] Community pharmacy managers' perception of computerized drug-drug interaction alerts
    Abarca, Jacob
    Malone, Daniel C.
    Skrepnek, Grant H.
    Rehfeld, Rick A.
    Murphy, John E.
    Grizzle, Amy J.
    Armstrong, Edward P.
    Woosley, Raymond L.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2006, 46 (02) : 148 - 153
  • [3] Reasons provided by prescribers when overriding drug-drug interaction alerts
    Grizzle, Amy J.
    Mahmood, Maysaa H.
    Ko, Yu
    Murphy, John E.
    Armstrong, Edward P.
    Skrepnek, Grant H.
    Jones, William N.
    Schepers, Gregory P.
    Nichol, W. Paul
    Houranieh, Antoun
    Dare, Donna C.
    Hoey, Christophe T.
    Malone, Daniel C.
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (10): : 573 - 580
  • [4] Physicians' responses to computerized drug-drug interaction alerts for outpatients
    Yeh, Min-Li
    Chang, Ying-Jui
    Wang, Po-Yen
    Li, Yu-Chuan
    Hsu, Chien-Yeh
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2013, 111 (01) : 17 - 25
  • [5] Practitioners' views on computerized drug-drug interaction alerts in the VA system
    Ko, Yu
    Ararca, Jagob
    Malone, Daniel C.
    Dare, Donna C.
    Geraets, Doug
    Houranieh, Antoun
    Jones, William N.
    Nichol, W. Paul
    Schepers, Gregory P.
    Wilhardt, Michelle
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2007, 14 (01) : 56 - 64
  • [6] A national survey on prescribers' knowledge of and their source of drug-drug interaction information
    Ko, Y.
    Malone, D. C.
    Skrepnek, G. H.
    Armstrong, E. P.
    Murphy, J. E.
    Abarca, J.
    Rehfeld, R. A.
    Reel, S. J.
    Woosley, R. L.
    VALUE IN HEALTH, 2007, 10 (03) : A28 - A29
  • [7] Development of computerized alerts with management strategies for 25 serious drug-drug interactions
    Murphy, John E.
    Malone, Daniel G.
    Olson, Bridget M.
    Grizzle, Amy J.
    Armstrong, Edward P.
    Skrepnek, Grant I.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (01) : 38 - 44
  • [8] THE EFFECT OF REDESIGNED COMPUTERIZED DRUG-DRUG INTERACTION ALERTS ON MEDICATION ERRORS AND PRESCRIBING EFFICIENCY
    Chen, S.
    Zillich, A. J.
    Melton, B. L.
    Saleem, J. J.
    Johnson, E.
    Weiner, M.
    Russell, S. A.
    McManus, M. S.
    Doebbeling, B. N.
    Russ, A. L.
    VALUE IN HEALTH, 2013, 16 (03) : A13 - A13
  • [9] Participatory design for drug-drug interaction alerts
    Luna, Daniel
    Otero, Carlos
    Almerares, Alfredo
    Stanziola, Enrique
    Risk, Marcelo
    Gonzalez Bernaldo de Quiros, Fernan
    DIGITAL HEALTHCARE EMPOWERING EUROPEANS, 2015, 210 : 45 - 49
  • [10] Consider the Content of Drug-Drug Interaction Alerts
    Sweidan, Michelle
    Reeve, James F.
    Dartnell, Jonathan G. A.
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (14) : 1338 - 1338